Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4435032
Max Phase: Preclinical
Molecular Formula: C46H57F3IN7O9S
Molecular Weight: 1067.97
Molecule Type: Unknown
Associated Items:
ID: ALA4435032
Max Phase: Preclinical
Molecular Formula: C46H57F3IN7O9S
Molecular Weight: 1067.97
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCOCCOCCNCCCONC(=O)c2ccc(F)c(F)c2Nc2ccc(I)cc2F)C(C)(C)C)cc1
Standard InChI: InChI=1S/C46H57F3IN7O9S/c1-28-41(67-27-53-28)30-8-6-29(7-9-30)24-52-44(61)37-23-32(58)25-57(37)45(62)42(46(2,3)4)55-38(59)26-65-21-20-64-19-18-63-17-15-51-14-5-16-66-56-43(60)33-11-12-34(47)39(49)40(33)54-36-13-10-31(50)22-35(36)48/h6-13,22,27,32,37,42,51,54,58H,5,14-21,23-26H2,1-4H3,(H,52,61)(H,55,59)(H,56,60)/t32-,37+,42-/m1/s1
Standard InChI Key: NJAUAZSSHDDOBK-DDMJSYEZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1067.97 | Molecular Weight (Monoisotopic): 1067.2935 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Wei J, Hu J, Wang L, Xie L, Jin MS, Chen X, Liu J, Jin J.. (2019) Discovery of a First-in-Class Mitogen-Activated Protein Kinase Kinase 1/2 Degrader., 62 (23): [PMID:31730343] [10.1021/acs.jmedchem.9b01528] |
2. Hu J,Wei J,Yim H,Wang L,Xie L,Jin MS,Kabir M,Qin L,Chen X,Liu J,Jin J. (2020) Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders., 63 (24.0): [PMID:33284613] [10.1021/acs.jmedchem.0c01609] |
Source(1):